Regulatory

>

Latest News

FDA Approves Merck’s Welireg for Advanced, Unresectable, or Metastatic Pheochromocytoma, Paraganglioma
FDA Approves Merck’s Welireg for Advanced, Unresectable, or Metastatic Pheochromocytoma, Paraganglioma

May 15th 2025

Welireg marks the first FDA-approved non-surgical treatment option for locally advanced, unresectable, or metastatic pheochromocytoma or paraganglioma in patients over 12 years of age.

FDA Grants Accelerated Approval to AbbVie’s Emrelis for Previously Treated, Locally Advanced or Metastatic Non-Squamous NSCLC
FDA Grants Accelerated Approval to AbbVie’s Emrelis for Previously Treated, Locally Advanced or Metastatic Non-Squamous NSCLC

May 15th 2025

Stock.adobe.com
NAMI Responds to Potential Cuts to Medicaid

May 15th 2025

FDA, CDC Recommend Pause on Valneva's Chikungunya Vaccine for Seniors
FDA, CDC Recommend Pause on Valneva's Chikungunya Vaccine for Seniors

May 14th 2025

President Donald Trump
Pharma Organizations Respond to Trump’s Most-Favored-Nation Policy

May 13th 2025

More News